The Patent Finder

Trident Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Trident Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Trident Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 7,914,791Vaccine
Lapsed on the fee record
Ended Mar 29, 2019 · From the USPTO record
Lapsed on the fee recordEnded Mar 29, 2019From the USPTO record
US 8,992,940Agent for treating allergic or hypersensitivity condition
Term ended
Ended no later than Jan 8, 2019 · From the USPTO record
Term endedEnded no later than Jan 8, 2019From the USPTO record
US 6,287,563Therapeutic agents and autoimmune diseases
Term ended
Term ended Dec 29, 2017 · From the USPTO record
Term endedTerm ended Dec 29, 2017From the USPTO record
US 7,588,763Methods for the prevention against or treatment of diabetes with ETXB and/or insulin
Formerly held
Lapsed on the fee record
Ended Sep 15, 2017 · From the USPTO record
Lapsed on the fee recordEnded Sep 15, 2017From the USPTO record
US 8,357,372Agent for treating allergic or hypersensitivity condition
Lapsed on the fee record
Ended Jan 22, 2017 · From the USPTO record
Lapsed on the fee recordEnded Jan 22, 2017From the USPTO record
US 7,208,155Agent for treating allergic or hypersensitivity condition
Lapsed on the fee record
Ended Apr 24, 2011 · From the USPTO record
Lapsed on the fee recordEnded Apr 24, 2011From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited